Download PDF
Fortschr Neurol Psychiatr 2020; 88(02): 121-138
DOI: 10.1055/a-1008-7510
Fort- und Weiterbildung

Akute psychotische Störungsbilder

Acute Psychotic Disorders
Susanne Englisch
,
Mathias Zink
› Further Information
    Permissions and Reprints

Akute psychotische Störungsbilder sind nicht auf organische Ursachen oder Substanzeinfluss zurückzuführen. Sie zeichnen sich durch einen akuten Beginn sowie diverse Symptome aus, die sowohl affektiver als auch produktiv-psychotischer und psychomotorischer Art sein können. Die Beschwerden remittieren meist binnen kurzer Zeit vollständig ohne nennenswerte Residuen, neigen jedoch zu rezidivierenden Verläufen. Auch sind Übergänge in andere Krankheitsbilder möglich.

Acute psychotic disorders (APS) are characterized by an acute onset as well as a wide array of symptoms including affective, psychotic, and psychomotor symptoms. They occur independently of substance use or organic disorders. In most cases, patients recover fully and without residues within a short period of time. However, APS tend to show a relapsing course, and transitions into other psychiatric disorders (schizophrenia, bipolar disorder) may occur.

Schlüsselwörter

Acute psychotic disorder - psychosisshizophrenia - antipsychotictreatment

Keywords

Acute psychotic disorder - psychosis - shizophrenia - antipsychotic - treatment


Publication History

Article published online:
26 February 2020

© Georg Thieme Verlag KG
Stuttgart · New York

 

  • Literatur

  • 1 Marneros A. Irrsal! Wirrsal! Wahnsinn! Persönlichkeit, Psychose und psychische Konflikte in Tragödien und Mythen: Stuttgart: Schattauer; 2013
  • 2 Castagnini AC, Fusar-Poli P. Diagnostic validity of ICD‑10 acute and transient psychotic disorders and DSM‑5 brief psychotic disorder. Eur Psychiatry 2017; 45: 104-113. DOI: 10.1016/j. eurpsy.2017.05.028.
    CrossrefPubMedGoogle Scholar
  • 3 Fusar-Poli P, Cappucciati M, Bonoldi I. et al. Prognosis of Brief Psychotic Episodes: A Meta-analysis. JAMA Psy 2016; 73: 211-220. DOI: 10.1001/jamapsychiatry.2015.231.
    CrossrefPubMedGoogle Scholar
  • 4 Wandinger KP, Leypoldt F, Junker R. Autoantikörper-vermittelte Enzephalitiden – Differenzialdiagnose bei Bewusstseinsstörungen unklarer Ätiologie. Dt Arztebl Int 2018; 115: 666-673
    PubMedGoogle Scholar
  • 5 Davies W. Understanding the pathophysiology of postpartum psychosis: Challenges and new approaches. World J Psych 2017; 7: 77-88. DOI: 10.5498/wjp.v7.i2.77.
    CrossrefPubMedGoogle Scholar
  • 6 Häfner H, Maurer K, Trendler G. et al. The early course of schizophrenia and depression. Eur Arch Psychiatry Clin Neurosci 2005; 255: 167-173
    CrossrefPubMedGoogle Scholar
  • 7 Eisenacher S, Rausch F, Ainser F. et al. Investigation of metamemory functioning in the at-risk mental state for psychosis. Psychol Med 2015; 45: 3329-3340. DOI: 10.1017/S0033291715001373.
    CrossrefPubMedGoogle Scholar
  • 8 Schultze-Lutter F, Michel C, Schmidt SJ. et al. EPA guidance on the early detection of clinical high risk states of psychoses. Eur Psychiatry 2015; 30: 405-416
    PubMedGoogle Scholar
  • 9 Bechdolf A, Pützfeld V, Güttgemanns JG. Kognitive Verhaltenstherapie bei Personen mit erhöhtem Psychoserisiko: Ein Behandlungsmanual. Bern: Hans Huber; 2015
    Google Scholar
  • 10 Marneros A, Pillmann F, Haring A. et al. Is the psychopathology of acute and transient psychotic disorder different from schizophrenic and schizoaffective disorders? Eur Psych 2005; 20: 315-320. DOI: 10.1016/j.eurpsy.2005.02.001.
    CrossrefPubMed
  • 11 Kahn RS, Winter van Rossum I, Leucht S. et al. Amisulpidrefe and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study. Lancet Psy 2018; 5: 797-807. DOI: 10.1016/s2215-0366(18)30252-9.
    CrossrefPubMedGoogle Scholar
  • 12 Häfner H, Maurer K, Löffler W. et al. The ABC Schizophrenia Study: a preliminary overview of the results. Soc Psych Epidemiol 1998; 33: 380-386
    CrossrefPubMedGoogle Scholar
  • 13 Jäger M, Bottlender R, Strauss A. et al. On the descriptive validity of ICD‑10 schizophrenia: empirical analyses in the spectrum of non-affective functional psychoses. Psychopathology 2003; 36: 152-159. DOI: 10.1159/000071260.
    CrossrefPubMedGoogle Scholar
  • 14 Pillmann F, Wustmann T, Marneros A. Acute and transient psychotic disorders versus persistent delusional disorders: a comparative longitudinal study. Psychiatry Clin Neurosci 2012; 66: 44-52. DOI: 10.1111/j.1440-1819.2011.02287.x.
    CrossrefPubMedGoogle Scholar
  • 15 Perälä J, Suvisaari J, Saarni SI. et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007; 64: 19-28. DOI: 10.1001/archpsyc. 64.1.19.
    CrossrefPubMedGoogle Scholar
  • 16 Singh SP, Burns T, Amin S. et al. Acute and transient psychotic disorders: precursors, epidemiology, course and outcome. Br J Psych 2004; 185: 452-459. DOI: 10.1192/bjp.185.6.452.
    CrossrefPubMedGoogle Scholar
  • 17 Castagnini A, Bertelsen A, Berrios GE. Incidence and diagnostic stability of ICD-10 acute and transient psychotic disorders. Compr Psychiatry 2008; 49: 255-261. DOI: 10.1016/j.comppsych. 2007.10.004.
    CrossrefPubMedGoogle Scholar
  • 18 Castagnini A, Foldager L. Variations in incidence and age of onset of acute and transient psychotic disorders. Soc Psychiatry Psychiatr Epidemiol 2013; 48: 1917-1922. DOI: 10.1007/s00127-013-0726-7.
    CrossrefPubMedGoogle Scholar
  • 19 Castagnini A, Foldager L, Bertelsen A. Excess mortality of acute and transient psychotic disorders: comparison with bipolar affective disorder and schizophrenia. Acta Psych Scand 2013; 128: 370-375. DOI: 10.1111/acps.12077.
    CrossrefPubMedGoogle Scholar
  • 20 Pillmann F, Balzuweit S, Haring A. et al. Suicidal behavior in acute and transient psychotic disorders. Psych Res 2003; 117: 199-209
    CrossrefPubMedGoogle Scholar
  • 21 Sajith SG, Chandrasekaran R, Sadanandan Unni KE. et al. Acute polymorphic psychotic disorder: diagnostic stability over 3 years. Acta Psych Scand 2002; 105: 104-109
    CrossrefPubMedGoogle Scholar
  • 22 Queirazza F, Semple DM, Lawrie SM. Transition to schizophrenia in acute and transient psychotic disorders. Br J Psych 2014; 204: 299-305. DOI: 10.1192/bjp.bp.113.127340.
    CrossrefPubMedGoogle Scholar
  • 23 Kørner A, Lopez AG, Lauritzen L. et al. Acute and transient psychosis in old age and the subsequent risk of dementia: a nationwide register-based study. Geriatr Gerontol Int 2009; 9: 62-68. DOI: 10.1111/j.1447-0594.2009.00505.x.
    CrossrefPubMedGoogle Scholar
  • 24 Marneros A, Pillmann F, Haring A. et al. Features of acute and transient psychotic disorders. Eur Arch Psych Clin Neurosci 2003; 253: 167-174. DOI: 10.1007/s00406-003-0420-y.
    CrossrefPubMedGoogle Scholar
  • 25 Jäger MR, Möller HJ. Akute vorübergehende psychotische Störungen (ICD‑10: F23): Empirische Befunde und Implikationen für die Therapie. Nervenarzt 2007; 78: 745-752. DOI: 10.1007/s00115-006-2211-y.
    CrossrefPubMedGoogle Scholar
  • 26 Korver-Nieberg N, Quee PJ, Boos HB. et al. The validity of the DSM‑IV diagnostic classification system of non-affective psychoses. Austr New Zeal J Psych 2011; 45: 1061-1068. DOI: 10.3109/00048674.2011.620562.
    CrossrefPubMedGoogle Scholar
  • 27 Ayesa-Arriola R, Rodriguez-Sanchez JM, Suero ES. et al. Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients. Eur Arch Psych Clin Neurosci 2016; 266: 619-628. DOI: 10.1007/s00406-015-0667-0.
    CrossrefPubMedGoogle Scholar
  • 28 Lyne J, OʼDonoghue B, Owens E. et al. Prevalence of item level negative symptoms in first episode psychosis diagnoses. Schizophr Res 2012; 135: 128-133. DOI: 10.1016/j. schres.2012.01.004.
    CrossrefPubMedGoogle Scholar
  • 29 Chaudhuri BP, Bhagabati D, Medhi D. Rispeidrefone versus halopeidrefol in acute and transient psychotic disorder. Indian J Psych 2000; 42: 280-290
    PubMedGoogle Scholar
  • 30 Pacciardi B, Calcedo A, Messer T. Inhaled Loxapine for the Management of Acute Agitation in Bipolar Disorder and Schizophrenia: Expert Review and Commentary in an Era of Change. Drugs R D 2019; 19: 15-25. DOI: 10.1007/s40268-019-0262-3.
    CrossrefPubMedGoogle Scholar
  • 31 Khanna A, Lal N, Dalal PK. et al. Treatment of acute and transient psychotic disorders with low and high doses of oral halopeidrefol. Indian J Psych 1997; 39: 136-142
    PubMedGoogle Scholar
  • 32 Jablensky A. Classification of nonschizophrenic psychotic disorders: a historical perspective. Curr Psych Rep 2001; 3: 326-331
    CrossrefPubMedGoogle Scholar
  • 33 Bighelli I, Salanti G, Huhn M. et al. Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta-analysis. J World Psych Assoc (WPA) 2018; 17: 316-329. DOI: 10.1002/wps.20577.
    CrossrefPubMedGoogle Scholar